Theseus Pharmaceuticals Inc
NASDAQ:THRX
Income Statement
Earnings Waterfall
Theseus Pharmaceuticals Inc
Revenue
|
0
USD
|
Operating Expenses
|
-66.5m
USD
|
Operating Income
|
-66.5m
USD
|
Other Expenses
|
9.9m
USD
|
Net Income
|
-56.6m
USD
|
Income Statement
Theseus Pharmaceuticals Inc
Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||||||||
Operating Expenses |
(16)
|
(22)
|
(27)
|
(33)
|
(39)
|
(47)
|
(54)
|
(61)
|
(66)
|
(67)
|
|
Selling, General & Administrative |
(4)
|
(6)
|
(9)
|
(12)
|
(15)
|
(17)
|
(18)
|
(19)
|
(19)
|
(19)
|
|
Research & Development |
(12)
|
(16)
|
(18)
|
(21)
|
(24)
|
(30)
|
(36)
|
(42)
|
(47)
|
(47)
|
|
Operating Income |
(16)
N/A
|
(22)
-38%
|
(27)
-27%
|
(33)
-22%
|
(39)
-16%
|
(47)
-22%
|
(54)
-14%
|
(61)
-12%
|
(66)
-9%
|
(67)
-1%
|
|
Pre-Tax Income | |||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
5
|
8
|
|
Total Other Income |
0
|
0
|
0
|
0
|
1
|
2
|
1
|
3
|
3
|
2
|
|
Pre-Tax Income |
(16)
N/A
|
(22)
-38%
|
(27)
-27%
|
(33)
-22%
|
(38)
-15%
|
(46)
-19%
|
(51)
-11%
|
(55)
-8%
|
(58)
-6%
|
(57)
+2%
|
|
Net Income | |||||||||||
Income from Continuing Operations |
(16)
|
(22)
|
(27)
|
(33)
|
(38)
|
(46)
|
(51)
|
(55)
|
(58)
|
(57)
|
|
Net Income (Common) |
(16)
N/A
|
(22)
-38%
|
(27)
-27%
|
(33)
-22%
|
(38)
-15%
|
(46)
-19%
|
(51)
-11%
|
(55)
-8%
|
(58)
-6%
|
(57)
+2%
|
|
EPS (Diluted) |
-0.42
N/A
|
-0.58
-38%
|
-0.71
-22%
|
-0.86
-21%
|
-0.98
-14%
|
-1.18
-20%
|
-1.31
-11%
|
-1.29
+2%
|
-1.32
-2%
|
-1.29
+2%
|